Publications by authors named "Jinoh Choi"

Background: Shortage of organ donors in the Republic of Korea has become a major problem. To address this, it has been questioned whether heart transplant (HTx) allocation should be modified to reduce priority of older patients. We aimed to evaluate post-HTx outcomes according to recipient age and specific pre-HTx conditions using a nationwide prospective cohort.

View Article and Find Full Text PDF

Sodium-glucose cotransporter 2 (SGLT-2) inhibitors are the only medications that improve clinical outcomes regardless of baseline left ventricular ejection fraction. Despite the recognized effectiveness of SGLT-2 inhibitors, there remains a paucity of research on the discontinuation of these medications. The objective of this study is to analyze the rate of discontinuation of SGLT-2 inhibitors, to evaluate the impact of discontinuation on the clinical outcome, and to identify the factors associated with discontinuation.

View Article and Find Full Text PDF

Background: Light chain amyloidosis, characterized by amyloid fibril deposition in multiple organs, often leads to progression to endstage kidney disease. This study aimed to identify predictors of kidney survival in patients with kidney amyloidosis, focusing on hematologic and kidney response.

Methods: This retrospective study included 138 patients diagnosed with kidney amyloidosis between 2011 and 2019.

View Article and Find Full Text PDF

Background And Objectives: The Korean Organ Transplant Registry (KOTRY) provided data for this third official report on adult heart transplantation (HT), including information from 709 recipients.

Methods: Data from HTs performed at seven major centers in Korea between March 2014 and December 2020 were analyzed, focusing on immunosuppression, acute rejection, cardiac allograft vasculopathy (CAV), post-transplant survival, and mechanical circulatory support (MCS) usage.

Results: The median ages of the recipients and donors were 56.

View Article and Find Full Text PDF
Article Synopsis
  • A study investigated the incidence and outcomes of COVID-19 vaccine-related pericarditis (VRP) in a large group of vaccinated Koreans from February to December 2021.
  • Out of over 44 million vaccinated individuals, 179 cases of VRP were confirmed, with a higher incidence in males, those under 40, and recipients of mRNA vaccines.
  • The condition was rare and had good outcomes, with no fatalities, though 5.6% of cases required drainage for significant pericardial effusion, indicating the need for monitoring.
View Article and Find Full Text PDF

Background: Although peripartum cardiomyopathy (PPCM) is a fatal disease affecting young patients and fetuses, little is known about its recent prognosis and risk factors. This study investigated temporal trends in clinical characteristics and outcomes for PPCM in a nationwide multicenter registry.

Methods And Results: The study population comprised 340 patients (mean age, 33 years) who were diagnosed with PPCM between January 2000 and September 2022 in 26 tertiary hospitals in South Korea.

View Article and Find Full Text PDF

Background And Objectives: The number of sensitized heart failure patients on waiting lists for heart transplantation (HTx) is increasing. Using the Korean Organ Transplantation Registry (KOTRY), a nationwide multicenter database, we investigated the prevalence and clinical impact of calculated panel-reactive antibody (cPRA) in patients undergoing HTx.

Methods: We retrospectively reviewed 813 patients who underwent HTx between 2014 and 2021.

View Article and Find Full Text PDF
Article Synopsis
  • Current heart failure (HF) guidelines recommend a comprehensive approach for management, including patient education and self-care, but implementing these recommendations is difficult in practice.
  • A study was conducted to test a mobile health (mHealth) platform that pairs a smartphone app with Bluetooth monitoring devices to improve self-management and symptoms of heart failure.
  • Results showed that the intervention group reported significantly better symptom improvement and adherence to the app compared to the control group, demonstrating the potential benefits of technology in managing HF.
View Article and Find Full Text PDF

The effect of changes in immunosuppressive therapy during the acute phase post-heart transplantation (HTx) on clinical outcomes remains unclear. This study aimed to investigate the effects of changes in immunosuppressive therapy by corticosteroid (CS) weaning and everolimus (EVR) initiation during the first year post-HTx on clinical outcomes. We analyzed 622 recipients registered in the Korean Organ Transplant Registry (KOTRY) between January 2014 and December 2021.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the eligibility of heart failure patients for dapagliflozin and its cost-effectiveness compared to standard therapy, using data from the Korean Acute Heart Failure registry.
  • About 48.7% of the patients met eligibility criteria from previous clinical trials, with higher eligibility found in those with preserved ejection fraction.
  • Dapagliflozin was found to be cost-effective, especially for patients with a left ventricular ejection fraction of 40% or less, showing a significant benefit in quality-adjusted life years at a cost well below standard willingness-to-pay thresholds.
View Article and Find Full Text PDF

Background: Iron deficiency is a common comorbidity in heart failure (HF) and is independently associated with a worse quality-of-life and exercise capacity, as well as increased risk of hospitalization, regardless of anemia status. Although international guidelines have provided recommendations for the management of iron deficiency in patients with HF, guidelines in Asia are less established, and practical use of guidelines for management of iron deficiency is limited in the region.

Methods: A panel comprising cardiologists from China, Hong Kong, India, Japan, Malaysia, Pakistan, Philippines, Singapore, South Korea, Taiwan, and Thailand convened to share insights and provide guidance for the optimal management of iron deficiency in patients with HF, tailored for the Asian community.

View Article and Find Full Text PDF

Background: Both stroke and right heart failure (RHF) are common and serious complications after left ventricular assist device (LVAD) implantation. The objective of this study was to evaluate relation between stroke and RHF early after LVAD implantation.

Methods: This is a retrospective observational cohort study.

View Article and Find Full Text PDF

The HeartWare Ventricular Assist Device (HVAD) was widely used for mechanical circulatory support in patients with end-stage heart failure. However, there have been reports of a critical issue with HVAD pumps failing to restart, or experiencing delays in restarting, after being stopped. This case report describes 2 instances of HVAD failure-to-restart during heart transplantation surgery and routine outpatient care.

View Article and Find Full Text PDF

Missense mutations in the alpha-B crystallin gene (CRYAB) have been reported in desmin-related myopathies with or without cardiomyopathy and have also been reported in families with only a cataract phenotype. Dilated cardiomyopathy (DCM) is a disorder with a highly heterogeneous genetic etiology involving more than 60 causative genes, hindering genetic diagnosis. In this study, we performed whole genome sequencing on 159 unrelated patients with DCM and identified an unusual stop-loss pathogenic variant in NM_001289808.

View Article and Find Full Text PDF
Article Synopsis
  • The FDA and EMA approved empagliflozin for reducing cardiovascular mortality and heart failure hospitalization in patients with HFrEF and HFpEF, but its real-world applicability is unclear.
  • A study analyzing data from the Korean Acute Heart Failure (KorAHF) registry found that 91.4% of patients met FDA/EMA criteria, while only 44.7% met trial criteria.
  • Empagliflozin was determined to be cost-effective at $6,764 per quality-adjusted life year (QALY), particularly for HFrEF patients ($5,012 per QALY), indicating potential benefits in clinical settings in South Korea.
View Article and Find Full Text PDF

Aims: Although the hypothesis that metformin is beneficial for patients with diabetes and heart failure (HF) has been steadily raised, there is limited data on metformin use in patients with acute HF. We analyzed the association of metformin on all-cause mortality in hospitalized patients with type 2 diabetes and acute HF.

Methods: The Korean Acute Heart Failure registry prospectively enrolled patients hospitalized for acute HF from 2011 to 2014.

View Article and Find Full Text PDF

With the increasing number of medications demonstrating mortality benefits in heart failure with reduced ejection fraction (HFrEF), the pharmacological treatment of HFrEF is entering a new phase. To enhance outcomes in heart failure patients through medical treatment, the choice of appropriate medications and simultaneous and rapid uptitration are critical. However, there are several challenges encountered during this medication uptitration, including issues like hypotension, fatigue, worsening renal function, and hyperkalemia.

View Article and Find Full Text PDF

The Korean Society of Heart Failure (KSHF) Guidelines provide evidence-based recommendations based on Korean and international data to guide adequate diagnosis and management of heart failure (HF). Since introduction of 2017 edition of the guidelines, management of advanced HF has considerably improved, especially with advances in mechanical circulatory support and devices. The current guidelines addressed these improvements.

View Article and Find Full Text PDF

Most patients with heart failure (HF) have multiple comorbidities, which impact their quality of life, aggravate HF, and increase mortality. Cardiovascular comorbidities include systemic and pulmonary hypertension, ischemic and valvular heart diseases, and atrial fibrillation. Non-cardiovascular comorbidities include diabetes mellitus (DM), chronic kidney and pulmonary diseases, iron deficiency and anemia, and sleep apnea.

View Article and Find Full Text PDF
Article Synopsis
  • The Korean Society of Heart Failure (KSHF) Guidelines offer evidence-based recommendations for diagnosing and managing heart failure, utilizing both Korean and international data.
  • The latest guidelines reflect significant advances in the treatment of advanced heart failure, particularly with mechanical circulatory support and devices since the 2017 edition.
  • Part IV of the guidelines focuses on the proper diagnosis and enhanced management strategies for both advanced and acute heart failure.
View Article and Find Full Text PDF
Article Synopsis
  • * Effective treatment for HF often includes a mix of medications like renin-angiotensin system inhibitors, diuretics, and anticoagulants based on specific conditions like atrial fibrillation or diabetes.
  • * Properly managing these comorbidities through medication and interventions like continuous positive airway pressure for sleep apnea is essential for better health outcomes in HF patients.
View Article and Find Full Text PDF

Background: Technetium-99 m 3,3-diphosphono-1,2-propanodicarboxylic acid (DPD) and technetium-99 m sodium pyrophosphate (PYP) are the two most commonly used radiotracers for cardiac amyloidosis (CA), but no studies have directly compared them. Therefore, in this study, we directly compared the diagnostic and clinical utility of DPD and PYP scintigraphy in patients with CA.

Methods: Ten patients with CA were enrolled.

View Article and Find Full Text PDF
Article Synopsis
  • A study investigated the role of left atrial appendage emptying velocity (LAAV) as a predictor of atrial fibrillation (AF) recurrence in patients undergoing totally thoracoscopic ablation (TTA).
  • Data was collected from 129 patients who underwent TTA, with findings indicating that lower LAAV was linked to higher rates of AF recurrence over a 3-year follow-up.
  • Patients with a LAAV below 20 cm/s had significantly worse event-free survival compared to those with higher LAAV, suggesting LAAV can help identify patients at risk for AF recurrence post-TTA.
View Article and Find Full Text PDF

Background: Although iron deficiency (ID) is an important and treatable risk factor for heart failure (HF), data on ID are scarce in Asian patients with HF. Therefore, we sought to determine the prevalence and clinical characteristics of ID in hospitalized Korean patients with HF.

Methods: In this prospective, multicenter cohort study, 461 patients with acute HF seen at five tertiary centers from January to November 2019 in Korea were enrolled.

View Article and Find Full Text PDF